Dean Jarnac - 15 Jun 2022 Form 4 Insider Report for Marvell Technology, Inc. (MRVL)

Role
EVP Worldwide Sales
Signature
Dean Jarnac by Blair Walters as Attorney-in-Fact
Issuer symbol
MRVL
Transactions as of
15 Jun 2022
Transactions value $
-$47,183
Form type
4
Filing time
17 Jun 2022, 18:40:26 UTC
Previous filing
19 Apr 2022
Next filing
19 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVL Common Stock Options Exercise $0 +1.93K +3.24% $0.00 61.6K 15 Jun 2022 Direct F1
transaction MRVL Common Stock Tax liability -$47.2K -959 -1.56% $49.20 60.6K 15 Jun 2022 Direct F2
holding MRVL Common Stock 24.9K 15 Jun 2022 By Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRVL Restricted Stock Units Options Exercise $0 -1.93K -49.99% $0.00 1.93K 15 Jun 2022 Common Stock 1.93K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 572 shares acquired under the Marvell 2000 Employee Stock Purchase Plan on June 7, 2022.
F2 Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs").
F3 Shares are held in a revocable trust. Dean and Megan Jarnac are trustees of the trust, of which their children are the beneficiaries.
F4 Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.
F5 The remaining RSUs will vest on 09/15/2022.